BR0013935A - IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos - Google Patents

IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos

Info

Publication number
BR0013935A
BR0013935A BR0013935-1A BR0013935A BR0013935A BR 0013935 A BR0013935 A BR 0013935A BR 0013935 A BR0013935 A BR 0013935A BR 0013935 A BR0013935 A BR 0013935A
Authority
BR
Brazil
Prior art keywords
ketotifen
hydroxy
isomers
ketotifene
racemic
Prior art date
Application number
BR0013935-1A
Other languages
English (en)
Portuguese (pt)
Inventor
A K Gunnar Aberg
George E Wright
Jan L Chen
Andrew T Maioli
Original Assignee
Bridge Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma Inc filed Critical Bridge Pharma Inc
Publication of BR0013935A publication Critical patent/BR0013935A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR0013935-1A 1999-09-13 2000-09-12 IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos BR0013935A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US15356699P 1999-09-13 1999-09-13
US19798500P 2000-04-15 2000-04-15
US19790600P 2000-04-15 2000-04-15
US19736300P 2000-04-15 2000-04-15
US19790500P 2000-04-15 2000-04-15
PCT/US2000/024892 WO2001019367A1 (en) 1999-09-13 2000-09-12 Optically active isomers of ketotifen and therapeutically active metabolites thereof

Publications (1)

Publication Number Publication Date
BR0013935A true BR0013935A (pt) 2002-05-14

Family

ID=27538454

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013935-1A BR0013935A (pt) 1999-09-13 2000-09-12 IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos

Country Status (18)

Country Link
US (3) US7226934B1 (cg-RX-API-DMAC7.html)
EP (1) EP1218007B1 (cg-RX-API-DMAC7.html)
JP (1) JP5116928B2 (cg-RX-API-DMAC7.html)
CN (1) CN1391475A (cg-RX-API-DMAC7.html)
AR (1) AR034396A1 (cg-RX-API-DMAC7.html)
AT (1) ATE516804T1 (cg-RX-API-DMAC7.html)
AU (1) AU782816B2 (cg-RX-API-DMAC7.html)
BR (1) BR0013935A (cg-RX-API-DMAC7.html)
CA (1) CA2383222C (cg-RX-API-DMAC7.html)
CY (1) CY1112605T1 (cg-RX-API-DMAC7.html)
DK (1) DK1218007T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0202671A3 (cg-RX-API-DMAC7.html)
IL (2) IL148368A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02002658A (cg-RX-API-DMAC7.html)
MY (1) MY134888A (cg-RX-API-DMAC7.html)
PL (1) PL353586A1 (cg-RX-API-DMAC7.html)
PT (1) PT1218007E (cg-RX-API-DMAC7.html)
WO (1) WO2001019367A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL353586A1 (en) * 1999-09-13 2003-12-01 Bridge Pharma, Inc.Bridge Pharma, Inc. Optically active isomers of ketotifen and therapeutically active metabolites thereof
WO2008153761A1 (en) * 2007-05-23 2008-12-18 Mastcell Pharmaceuticals, Inc. Methods
WO2009142772A2 (en) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
AU2009257259B2 (en) 2008-06-13 2013-05-02 Case Western Reserve University Compostions and methods for treating corneal inflammation
WO2010047681A1 (en) * 2008-10-24 2010-04-29 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
WO2010059894A1 (en) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Ocular formulations of norketotifen
JP2012520880A (ja) * 2009-03-17 2012-09-10 アーシエックス セラピューティックス, インコーポレイテッド ケトチフェンの眼科用製剤および使用方法
US9296731B2 (en) 2011-06-28 2016-03-29 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Anti-allergy benzocycloheptathiophene derivatives
US8557846B1 (en) 2012-10-23 2013-10-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in dogs
US8778971B2 (en) 2012-10-23 2014-07-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in companion animals
US20150272941A1 (en) * 2012-10-30 2015-10-01 Bridge Pharma, Inc. Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen
US20140120121A1 (en) * 2012-10-30 2014-05-01 Bridge Pharma, Inc. Medicinal treatment of atopic inflammatory diseases
US9138431B2 (en) * 2013-08-06 2015-09-22 Bridge Pharma, Inc. Methods of treatment of histamine H-4 receptor-related pruritus
US9345697B2 (en) * 2013-08-06 2016-05-24 Bridge Pharma, Inc. Methods of treatment of non-histaminic pruritus
US9439895B2 (en) * 2013-08-06 2016-09-13 Bridge Pharma, Inc. Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients
CN104059056B (zh) * 2014-06-26 2017-08-25 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬晶型b及其制备方法
EP3307270B1 (en) * 2015-06-11 2018-10-17 Bridge Pharma, Inc. Methods of treatment of non-histaminic pruritus in mammals
US9694003B2 (en) 2015-10-15 2017-07-04 Bridge Pharma, Inc. Formulations and methods for treating high intraocular pressure
CN106243096B (zh) * 2016-07-29 2019-11-29 上海璃道医药科技有限公司 三环类药物的新用途
MY204310A (en) 2016-09-08 2024-08-22 Emergo Therapeutics Inc Mast cell stabilizers for treatment of hypercytokinemia and viral infection
US11478463B2 (en) 2016-10-18 2022-10-25 Emergo Therapeutics, Inc. Mast cell stabilizers for treatment of chronic inflammatory conditions
US20200268734A1 (en) * 2019-02-22 2020-08-27 Bridge Pharma, Inc. Methods of treatment of respiratory disorders
US10959992B2 (en) 2019-02-22 2021-03-30 Bridge Pharma Inc. Methods of treatment of asthma and COPD

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1089483A (en) 1964-02-04 1967-11-01 Sandoz Ltd Improvements in or relating to 4h-benzo(4,5)cyclohepta (1,2-b) thiophene derivatives
FR1447527A (fr) 1964-08-11 1966-07-29 Sandoz Sa Nouveaux benzo-cyclohepta-thiophènes et leur préparation
CH531000A (de) 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
BE794377A (fr) * 1972-01-24 1973-07-23 Sandoz Sa Nouveaux derives du benzo-cyclohepta-thiophene
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
US4073915A (en) 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
US4128549A (en) 1976-02-27 1978-12-05 Sandoz Ltd. Precursors of 4-(1-alkyl-4-piperidylidene-4H-benzo[4,5]cyclohepta-[1,2-b]thiophen-10(9H)-ones
CS263993B1 (cs) 1988-03-11 1989-05-12 Polivka Zdenek Způsob přípravy čistých enantiomerů 4- (l-meíhyl-4-piperidyliden) -4,9-dihydrobenzo [ 4,5) cyklohepta [ 1,2-b ] - thiofen-lQ-onu
MY106964A (en) * 1988-04-28 1995-08-30 Schering Corp Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents.
GB9012926D0 (en) * 1990-06-09 1990-08-01 Scras Pyrrolo-pyridine derivatives
US5416087A (en) * 1990-10-10 1995-05-16 Wong; Jesse K. Bis-benzo, cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use
JP3026841B2 (ja) * 1991-12-12 2000-03-27 グラクソ、グループ、リミテッド 医 薬
CA2123909C (en) * 1991-12-18 2002-10-01 Christer Carl Gustav Carling New combination of formoterol and budesonide
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
PL336007A1 (en) 1997-04-03 2000-06-05 Bridge Pharma Chemical compounds of benzocycloheptathiophene
US6207684B1 (en) * 1997-06-09 2001-03-27 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
PL353586A1 (en) * 1999-09-13 2003-12-01 Bridge Pharma, Inc.Bridge Pharma, Inc. Optically active isomers of ketotifen and therapeutically active metabolites thereof

Also Published As

Publication number Publication date
AR034396A1 (es) 2004-02-25
WO2001019367A1 (en) 2001-03-22
JP5116928B2 (ja) 2013-01-09
EP1218007A1 (en) 2002-07-03
PL353586A1 (en) 2003-12-01
HUP0202671A3 (en) 2005-01-28
ATE516804T1 (de) 2011-08-15
DK1218007T3 (da) 2011-11-07
CA2383222A1 (en) 2001-03-22
CY1112605T1 (el) 2016-02-10
US7557128B2 (en) 2009-07-07
PT1218007E (pt) 2011-10-27
AU7701400A (en) 2001-04-17
US7872025B2 (en) 2011-01-18
MXPA02002658A (es) 2002-10-23
MY134888A (en) 2007-12-31
EP1218007A4 (en) 2003-04-09
US20080287498A1 (en) 2008-11-20
CA2383222C (en) 2008-11-18
EP1218007B1 (en) 2011-07-20
IL148368A (en) 2007-10-31
JP2003509369A (ja) 2003-03-11
CN1391475A (zh) 2003-01-15
AU782816B2 (en) 2005-09-01
HUP0202671A2 (hu) 2002-11-28
US20090149502A1 (en) 2009-06-11
US7226934B1 (en) 2007-06-05
IL148368A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
SE9704869D0 (sv) New pharmaceutical formulaton II
DK0650483T3 (da) (3R,4R)-Delta6-tetrahydrocannabinol-7-syrer
MY119403A (en) Novel compounds with analgesic effect.
TR200103493T2 (tr) Metaloproteaz önleyicileri
BR9712085A (pt) Inibidores de metaloprotease heterocìclicos
MY134888A (en) Optically active isomers of ketotifen and therapeutically active metabolites thereof
MY132705A (en) Novel compounds with analgesic effect
IT1283102B1 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
SE9900961D0 (sv) Novel compounds
DE69935720D1 (de) Diamino-propanol-verbindungen zur behandlung von ischaemien
DE69034070D1 (de) Racemisches Huperzin A
SE9802208D0 (sv) Novel compounds
TR200000737T2 (tr) İkame edilmiş kroman türevleri.
FI955260A7 (fi) Transdermaalisia terapeuttisia systeemejä serotoniiniagonistien antami sta varten
NO20013414D0 (no) Ny anvendelse av melagatran
ATE360428T1 (de) Analgetisches arzneimittel
SE9802209D0 (sv) Novel compounds
SE9504662D0 (sv) New compounds
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
NO20032006D0 (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
BR0015404A (pt) Compostos relacionados com ácido 15-hidroxieicosatetraenóico e métodos de uso
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
SE0004827D0 (sv) Therapeutic compounds
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S)8O, 10, 11 E25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.